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COMMENTARY 
Adolescence and young adulthood may be characterized as a time of becoming.1 It is a time of 
significant personal and professional growth and of recognizing major life milestones such as 
graduations, jobs, and new relationships. Almost 90,000 adolescents and young adults (AYAs) in 
the United States are diagnosed with cancer annually,2 experiencing it as a significantly 
distressing, widely disruptive, and singularly defining event in their lives. For AYAs with 
cancer, their “time of becoming” is often characterized by adapting to a wide-ranging number of 
challenges that compromise their physical, emotional, and social development and health-related 


















treatment milestones such as completing chemotherapy, receiving “clean” scans, and returning to 
work or school.7-10 Among AYAs, cancer is the most common disease-related cause of death for 
females, and second only to heart disease for males2,11 yet the vast majority of AYAs will 
survive their disease with the average five-year survival rate of >80%.12-14 Unfortunately, many 
AYA survivors report poorer HRQOL relative to their healthy peers3,4 and are at increased risks 
of cancer-related infertility, financial hardship, recurrence, second primary cancers, and 
symptom burden for late and long-term effects.15-17  
Despite the unique needs and challenges of being diagnosed with and surviving cancer as an 
AYA, the HRQOL experiences of AYAs are rarely evaluated as part of clinical trials,18 nd 
when they are assessed, they are inconsistently and incompletely captured by existing patient-
reported outcome (PRO) measures. In 2013, the National Cancer Institute (NCI) held a State of 
the Science meeting to review and discuss current gaps in the evidence-base for AYA oncology 
across epidemiology, basic biology, clinical trials, health services and medical care, and HRQOL 
research.14 Key findings and future directions to advance AYA oncology research were 
summarized in a special “Adolescent and Young Adult Series” published in the spring of 2016 in 
the journal Cancer. Among the consensus recommendations for “next steps” from the HRQOL 
working group was the following: “Valid, reliable, developmentally relevant, and 
psychometrically robust measures of HRQOL, overall and by subdomain, are needed that cross 
the age spectrum and allow for studies of the full AYA age range.”14  
More recently, the Childhood Cancer Data Initiative (CCDI) highlighted a similar need “to 
collect, analyze, and share data to address the burden of cancer in children and AYAs.”19 The 
CCDI has called for a better understanding of the barriers to PRO data collection in pediatric and 
AYA studies as well as increased use of valid and reliable assessment measures. Common 
barriers to completion of PROs can occur at both the patient and the clinic levels. At the patient 
level, factors that decrease completion rates can include respondent burden, measures that are not 
content or culturally relevant to the patient experience, or are poorly written (colloquial, double-
barreled, or have high literacy levels), and are only available in English. At the provider/clinic 
level, PROs are not always integrated into the electronic medical record or the existing 
workflow, paper forms can be misplaced, and scoring of measures may not be interpretable or 
actionable. Collectively, these factors contribute to the relatively low yield of PRO data from 
AYAs to inform future research and cancer care.   
In this commentary, our goal is to highlight the benefit of applying scale development 
methodologies from the NIH’s Patient-Reported Outcome Measurement Information System® 
(PROMIS®) to the field of HRQOL measurement among AYAs affected by cancer. This can be 
done in two ways: 1) using existing PROMIS measures that are relevant to the life experiences of 
AYAs, and 2) using PROMIS methodologies to developing new measures for AYAs where gaps 


















science of PROs and is an NIH Roadmap initiative designed to improve assessment of PROs 
using modern psychometric methods.20,21 The main focus of the PROMIS initiative has been on 
developing instruments to assess health status for chronic disease conditions across the age range 
from pediatrics to adults. Adapting the World Health Organization’s tripartite framework of 
physical, mental, and social health,22 PROMIS has developed and calibrated measures to capture 
multiple areas of health and functioning23-31 and has extensive evidence of its validity and 
reliability in both pediatric and adult cancer populations.32-39 
HRQOL measurement in AYAs 
AYAs with cancer represent a wide range of both disease types and developmental stages with a 
correspondingly wide range of HRQOL priorities. The most common cancer types among AYAs 
are breast, thyroid, hematologic malignancies, germ cell, and melanoma.40 Developmentally, the 
AYA age group captures at least three distinct subgroups of adolescents (ages 15 to 17), 
emerging adults (ages 18 to 25), and young adults (ages 26 to 39).41 This level of disease and 
developmental heterogeneity results in an understandably broad range of HRQOL domains 
impacted by cancer and a lack of consensus regarding standardized assessment of HRQOL for 
AYAs. A recent systematic literature review identified the following core domains of HRQOL 
for AYAs: physical, cognitive, emotional, restricted activities, relationships with others, fertility, 
body image, and spirituality/outlook on life.42 In an observational study of developmentally 
diverse AYA patients and survivors, their most important HRQOL domains were physical 
function, pain, cognitive function, social support, and finances.43,44 The importance of individual 
HRQOL domains varied based on age subgroup and treatment status. Pain was more frequently 
ranked as a priority domain for on-treatment AYAs than for off-treatment AYAs, and finances 
were more commonly ranked by older AYAs. In the largest, population-based study of HRQOL 
in AYAs, the NCI’s Adolescent & Young Adult Health Outcomes & Patient Experience (AYA 
HOPE) study,45 the most common negative psychosocial life disruptions reported by AYAs 
(regardless of age cohort) were finances, body image, and fertility/parenthood.46  
Unfortunately, existing HRQOL measures for AYAs are often limited in several important ways: 
content that is not specific to AYAs’ unique HRQOL needs or appropriate for their age group, 
questions that are not perceived to be relevant to AYAs, summary scores that lack meaningful 
reference values or norms, and questions that describe concepts in idiomatic or culturally-biased 
ways or are otherwise not translatable.43,47-49 Thus, there is a clear need for psychometrically-
robust measures of HRQOL to be used with AYAs that capture meaningful constructs. Rather 
than reinvent the wheel, it is important to provide a clearer delineation of the appropriateness of 
existing HRQOL measurement frameworks and identify any existing gaps in HRQOL domains 
for AYAs with cancer. Existing measures of HRQOL may be generic, providing global 
evaluations of HRQOL across broad domains of physical, mental, and social health, or they may 


















these measures may be developed for and validated with pediatric and adolescent populations 
(e.g, ages 8 to 17 years), or adult populations (18 years or older). Applying these tools for AYA 
research is challenging when the cohort crosses the common threshold of 18 years of age. Instead 
of using both pediatric and adult HRQOL measure for conducting research on AYAs, a single 
AYA HRQOL profile measure with a select number of short forms that captures the relevant 
HRQOL domains from 15 to 39 years of age would be ideal.  
An informal review of generic and cancer-specific HRQOL measures for pediatric and AYA 
populations (Table 1) identified cross-cutting themes of physical, mental, and social HRQOL. 
Additional areas of relevance to AYAs’ HRQOL are not easily captured by these three over-
arching themes and comprise a fourth category for “other” HRQOL concerns (e.g., school, 
work). Only two measurement frameworks cover the entire AYA age range from 15 to 39 years 
of age: the Pediatric Quality of Life Inventory (PedsQL)50-52 which has separate, partially 
overlapping forms for adolescents, emerging adults, and young adults; and the Minneapolis-
Manchester Quality of Life Survey of Health (MMQL),53,54 which has separate, non-parallel 
forms for adolescents and young adults. Notably, several important aspects of the AYA 
experience (i.e., financial burden,48,55 body image concerns,42,48 and fertility/parenthood 
concerns42,47), are rarely and inconsistently measured by these measures.  
Advantages of PROMIS 
PROMIS includes over 300 measures of physical, mental, and social HRQOL from among 102 
adult and 25 pediatric domains.56 The PROMIS approach involves iterative steps of 
comprehensive literature searches, development of conceptual frameworks through concept 
elicitation interviews, identifying and categorizing items, qualitative assessment of items using 
focus groups and cognitive interviews, and quantitative evaluation of items using techniques 
from both classical test theory and item response theory.20,21,33,57-59 To assist developers in 
meeting the scientific standard criteria for assessing PROs, the PROMIS investigators created an 
Instrument Maturity Model.33 This model describes the five stages of instrument development 
from latent trait or domain conceptualization to evidence of psychometric properties in multiple 
clinical samples (Figure 1).  
What makes PROMIS stand apart from other established HRQOL measures is that each HRQOL 
domain measured by PROMIS is captured by an item bank. Other established HRQOL measures 
have a limited number of questions to assess each HRQOL construct (e.g., 6 questions on 
fatigue, 8 questions on physical functioning). The PROMIS item banks (one bank for each PRO) 
include a much larger number of questions that have undergone extensive testing using 
qualitative and quantitative methods. Every PROMIS measure draws a select number of 
questions from the item bank to provide a reliable and valid assessment of the HRQOL domain 
of interest. For example, selecting 10 fatigue questions out of the 95 fatigue questions in the 


















as fixed-length short forms. This version of the PROMIS measure means that everyone in the 
study answers the same set of questions (e.g., the 10-question fatigue measure). An alternate way 
to administer PROMIS measures is through computer adaptive testing (CAT). CAT-based 
assessment individually tailors the measure to each individual based on her/his responses to each 
question administered. Compared to fixed-length short forms, the CAT can reduce the number of 
questions being administered (e.g., maybe 5 instead of 10 questions) and achieve appropriately 
reliable measurement.  Because all PROMIS measures (fixed-length short forms or CAT-based 
assessment) use items selected from the same PROMIS item bank, the scores can be compared or 
combined together across the measures. 
A particular challenge within AYA HRQOL measurement is that both pediatric and adult 
perspectives are represented within the 15-39 age range. Previous testing of PROMIS measures 
was conducted with a broad age range (8-17 years and 18-99+ years) and did not include a 
specific focus on AYAs. Linking analyses provide an approach to “connect” the pediatric and 
adult forms in physical and emotional health domains.60,61 Alternatively, many of the adult items 
may prove reliable and valid for administration with older adolescents (ages 15 to 17) precluding 
the need for multiple forms. A unique strength of item banking and CAT is the flexibility in 
administration within a diverse sample. For example, younger and older AYAs may have 
different social health needs and priorities. A core set of items could be selected from within the 
PROMIS social health bank that can form a fixed-length short form across the entire AYA age 
range and be supplemented with additional items from the bank for specific age groups (younger 
vs older AYAs) to allow for greater measurement precision. This approach would provide 
tailoring at the item content level while also preserving comparability of scores within the full 
AYA age range. 
Leveraging PROMIS standards and methodology is an important next step to improve 
assessment of HRQOL in AYAs with cancer. PROMIS can serve as a blueprint for researchers 
interested in developing new measures that have the same high standards as PROMIS as well as 
extending existing PROMIS measures to new clinical populations of interest (e.g., AYAs). 
Accordingly, developing new item banks to assess financial burden, body image concerns, and 
fertility/parenthood concerns among AYAs will allow the creation of optimal short forms and 
CATs. These tools should be designed following the PROMIS Scientific Standards58 an  related 
COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN).62-
65 By adhering to this rigorous stepwise approach to PRO development and testing, PROMIS can 
be effectively used to address many of the challenges in measuring AYAs’ HRQOL (Table 2). 
Conclusion 
The NCI issued a clear call for a more psychometrically robust approach to measurement science 
in AYA oncology, a call that has been echoed by the Childhood Cancer Data Initiative. 


















understanding of the patient experience and may ultimately contribute to a more efficient 
identification of AYA patients at risk for psychosocial distress and deleterious outcomes. There 
is growing awareness in the oncology field that PROs are valuable to capture the patient 
experience to evaluate treatment efficacy and safety and should be routinely collected in trials.66-
71 Additional buy-in and sustained support from funding and regulatory agencies, and from 
leaders of oncology cooperative groups and review committees is needed to further catalyze 
PRO research in AYA oncology. A measurement system that is flexible, efficient, reliable, age-
appropriate, relevant, comprehensible, interpretable, and translatable holds the potential to 
significantly elevate AYA  clinical care and research pursuits. PROMIS provides this needed 
















Table 1 Common Measures and Domains for Assessing HRQOL in AYAs 
 MMQL Adolescent & 
Young Adult Forms 
PedsQL 4.0 Generic 
& 3.0 Cancer Module 
PCQL-32 &  
PCQL Modular LAYA-SRQL IOC-CS 
for 
ages: 
13-20 & 21-45 years 13-18, 18-25, 
25+ years 
8-18 years 18-39 years 18-39 years 
Physical • Physical 
• Body Image 
•Physical Functioning 
•Pain and Hurt 
•Nausea 







































•Talking with Parents 
•Socializing 
Other  •School Functioning  •Healthcare 
•Education/ Career 
•Health Literacy 
• Financial Problems 
Note: Bold font indicates the presence of financial burden, body image, and fertility/parenthood dimensions captured by existing measures.  
MMQL Adolescent = Minneapolis-Manchester Quality of Life instrument Adolescent form53; MMQL Young Adult = Minneapolis-Manchester 
Quality of Life instrument Young Adult form54  
PedsQL 4.0 Generic = Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales50; PedsQL 3.0 Cancer Module = Pediatric Quality of 
Life Inventory Cancer Module51 
PCQL-32 = Pediatric Cancer Quality of Life Inventory-3272; PCQL Modular = Pediatric Cancer Quality of Life Inventory-Modular73 
LAYA-SRQL=Late Adolescence and Young Adulthood-Survivorship-Related Quality of Life Scale74 

















Figure 1. PROMIS Instrument Maturity Model 
 

















Table 2 – AYA HRQOL Measurement Challenges and Potential Solutions 
AYA HRQOL PRO measures need 
to be… 
PROMIS provides… 
Flexible Fixed short forms or computer adaptive testing 
Efficient Minimal response burden by selecting most 
relevant questions 
Reliable Includes questions that demonstrate high ability 
to differentiate among individuals HRQOL 
levels. 
Age-appropriate Adult PROMIS questions are ≤ 6th grade reading 
level 
Relevant Wide range of HRQOL domains can be assessed 
by PROMIS* 
Comprehensible Vetted through cognitive interviews with a 
diverse sample of individuals in respect to age, 
education, race/ethnicity, and health status. 
Interpretable Uses easily interpretable T-score metric with 
reference scores to the US general population. 
Translatable Available in Spanish and other languages 
Note: *PROMIS HRQOL domains overlap with the majority of important HRQOL domains for 
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